Skip to main content
. 2021 Dec 11;39(1):221–243. doi: 10.1007/s12325-021-01992-4

Table 3.

Patients within dataset of specific conditions previously associated with narcolepsy: control subjects versus subjects with narcolepsy [22]

CCS category or ICD-9 diagnosis code Patients with comorbidity, n (%) Excess prevalence p valuea Odds ratiob (95% CI)
Control
N = 46,559
Narcolepsy
N = 9312
Anxiety disorders (651) 5554 (11.9) 2333 (25.1) 13.2% < 0.0001 2.5 (2.4, 2.7)
Diabetes (49, 50) 8835 (19.0) 2635 (28.3) 9.3% < 0.0001 1.8 (1.7, 1.8)
Headache/migraine (84) 8424 (18.1) 3548 (28.3) 20% < 0.0001 2.9 (2.8, 3.1)
Mood disorders (657) 6407 (13.8) 3525 (37.9) 24.1% < 0.0001 4.0 (3.8, 4.2)
Obesity (3.11.2) 3933 (8.4) 1609 (17.3) 8.8% < 0.0001 2.3 (2.2, 2.5)
Periodic limb movement disorder (327.51) 2675 (5.8) 369 (4.0) 3.7% < 0.0001 14.8 (12, 18.1)
Sleep apnea (327.20, 327.21, 327.23, 327.27, and 3327.29) 2675 (5.8) 4787 (51.4) 45.6% < 0.0001 18.7 (17.5, 20.0)
REM behavior disorder (327.42) 5 (0) 44 (0.5) 0.5% < 0.0001 44 (17.4, 111)
Restless leg syndrome (333.94) 307 (0.7) 517 (5.6) 4.9% < 0.0001 8.9 (7.7, 10.3)

Reproduced with permission from Black et al. [22]

CCS Clinical Classification Software, REM rapid eye movement

aConditional chi-squared test; accounts for matching

bOdds ratios interpreted as narcolepsy versus control